Nalaganje...

Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease

OBJECTIVES: Human anti-chimeric antibodies (HACAs) and subtherapeutic infliximab concentrations are associated with decreased duration of response. We evaluated the clinical utility of measuring HACA and infliximab concentrations. METHODS: The medical records of patients with inflammatory bowel dise...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Gastroenterol
Main Authors: Afif, Waqqas, Loftus, Edward V., Faubion, William A., Kane, Sunanda V., Bruining, David H., Hanson, Karen A., Sandborn, William J.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937708/
https://ncbi.nlm.nih.gov/pubmed/20145610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2010.9
Oznake: Označite
Brez oznak, prvi označite!